Ocuphire Pharma (OCUP)
(Real Time Quote from BATS)
$1.97 USD
-0.02 (-1.01%)
Updated Jul 22, 2024 12:34 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.29 |
EPS Last Quarter | -0.29 |
Last EPS Surprise | -61.11% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.16 |
Next Year | -0.52 |
EPS (TTM) | -0.49 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.80M | 1.89M | 7.34M | 33.63M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 1.80M | 1.89M | 7.34M | 33.63M |
Low Estimate | 1.80M | 1.89M | 7.34M | 33.63M |
Year ago Sales | 3.67M | 11.94M | 19.05M | 7.34M |
Year over Year Growth Est. | -50.95% | -84.17% | -61.47% | 358.17% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.29 | -0.29 | -1.16 | -0.52 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.29 | -0.29 | -1.16 | -0.52 |
High Estimate | -0.29 | -0.29 | -1.16 | -0.52 |
Low Estimate | -0.29 | -0.29 | -1.16 | -0.52 |
Year ago EPS | -0.24 | 0.25 | -0.46 | -1.16 |
Year over Year Growth Est. | -20.83% | -216.00% | -152.17% | 55.17% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.29 | -0.29 | -1.16 | -0.52 |
7 Days Ago | -0.29 | -0.29 | -1.16 | -0.52 |
30 Days Ago | -0.29 | -0.29 | -1.16 | -0.52 |
60 Days Ago | -0.29 | -0.29 | -1.16 | -0.52 |
90 Days Ago | -0.18 | -0.19 | -0.53 | -0.42 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.29 | -0.29 | -1.16 | -0.52 |
Zacks Consensus Estimate | -0.29 | -0.29 | -1.16 | -0.52 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.29 | -0.21 | 0.25 | -0.24 | NA |
Estimate | -0.18 | -0.07 | -0.32 | -0.36 | NA |
Difference | -0.11 | -0.14 | 0.57 | 0.12 | 0.11 |
Surprise | -61.11% | -200.00% | 178.13% | 33.33% | -12.41% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more